No scientific studies have established a causal relationship between the Pfizer vaccine and conditions that cause the excessive growth of breasts.

This month, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US.

UK women report significant breast enlargement after Pfizer COVID-19 vaccine. Possible link to rare condition PASH, but requires further research.

CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in oncology and obesity.

Pfizer's Phase III trial of sasanlimab with BCG in subjects with BCG-naïve, high-risk NMIBC, has met its primary endpoint.